You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 150 No. 2, February 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  REVIEW ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nonsteroidal Anti-inflammatory Drug Nephrotoxicity

Should We Be Concerned?

M. Thomas Stillman, MD; Peter A. Schlesinger, MD

Arch Intern Med. 1990;150(2):268-270.


Abstract

• Various nephrotoxicity syndromes are seen with the use of nonsteroidal anti-inflammatory drugs (NSAIDs). The most common is reversible, hemodynamically mediated renal insufficiency. The role of prostaglandin inhibition by NSAIDs is discussed in the context of renal prostaglandin physiology. Potential differences among NSAIDs are reviewed. The "renal sparing" effect of sulindac may be attributable to the relative preservation of renal prostaglandin synthesis. Salsalate, although anti-inflammatory, demonstrates weak prostaglandin inhibition at therapeutic doses. A framework is developed for the clinical application of these considerations. Along a continuum of increasing risk factors for NSAID nephrotoxicity, or increasing NSAID dose, there likely exists a therapeutic window where differences among NSAIDs are most relevant.

(Arch Intern Med. 1990;150:268-270)



Author Affiliations

From the Rheumatology Division, Department of Medicine, Hennepin County Medical Center and the University of Minnesota Medical School, Minneapolis.


Footnotes

Accepted for publication July 24,1989.

Presented at the 52nd Annual Meeting of the American Rheumatism Association, Houston, Tex, May 25,1988.

Reprint requests to the Department of Medicine, Hennepin County Medical Center, 701 Park Ave S, Minneapolis, MN 55415 (Dr Stillman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure
Pope et al.
Arch Intern Med 1993;153:477-484.
ABSTRACT  

Cost-Conscious Prescribing of Nonsteroidal Anti-inflammatory Drugs for Adults With Arthritis: A Review and Suggestions
Greene and Winickoff
Arch Intern Med 1992;152:1995-2002.
ABSTRACT  

Tell Your Kidneys to Take a Powder
Mitchell
Arch Intern Med 1991;151:617-617.
ABSTRACT  

Nonsteroidal Anti-inflammatory Drug--Associated Azotemia in the Very Old
Gurwitz et al.
JAMA 1990;264:471-475.
ABSTRACT  

Adverse Effects of Nonsteroidal Anti-inflammatory Drugs on Renal Function
Murray and Brater
ANN INTERN MED 1990;112:559-560.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.